- Display 15 Products per page
Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)
Published: February 1, 2012 | Price: $2,500.00 – $5,000.00
Vaccines are among the top revenue earners in recent years, and in some cases have assisted major pharmaceutical companies to revenue growth. But this is not without some trade-offs. Vaccines involve a complex production process. Is vaccine-making profitable? How much is the industry spending? How much is handed off to other companies and how much is made by the branded manufacturers? How many doses are produced by the industry? These are the type of questions that Kalorama Information has taken...
World Market for Gastrointestinal Devices (Rigid, Flexible and Capsule Endoscopes, Bariatric Surgery, Ostomy Products, Enteral Feeding Pumps and Other Devices)
Published: January 1, 2012 | Price: $2,500.00 – $5,000.00
This report, The World Market for Gastrointestinal Devices, details the market for endoscopes and other devices used for treating gastrointestinal conditions. There are many factors behind the growth of this market. Cancer is one of leading reasons for surgery with more than 1 million new cases of colorectal cancer reported each year around the world. Obesity is another reason for growth. More and more people worldwide are turning to gastric bypass (bariatric surgery) and gastric banding to aide in their...
World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition, The
Published: January 1, 2012 | Price: $1,995.00 – $4,995.00
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, - Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives - Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar, with Market Share for each Hormone Therapy: - Subcategories include Corticosteroids, Hormone...
Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
Published: January 1, 2012 | Price: $1,995.00 – $3,990.00
There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....
US Pharmaceutical, Medical Device, Diagnostics Markets
Published: December 1, 2011 | Price: $150.00 – $300.00
Kalorama Information reports on a wide range of topics related to healthcare industry markets in the United States. This report, The Kalorama U.S.Pharmaceutical, Medical Device, Diagnostics Markets provides a broad look at the healthcare system and a summary of the market for the healthcare industry in the United States. The report discusses a range of topics impacting the industry: Healthcare Reform - What Impact Will Be Had on Each Healthcare Industry? How Will Physicians, Patients, Payors, and the Uninsured Be...
World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants), The
Published: November 1, 2011 | Price: $150.00 – $300.00
Arthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthritis family is rheumatoid arthritis, which is an autoimmune disease. Successful treatment of arthritis has resulted from a growing array of therapies available to physicians. While these pharmaceutical products are still used regularly, new disease-modifying therapies have produced the most impressive results in treating more severe types of arthritis....
Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
Published: November 1, 2011 | Price: $150.00 – $300.00
Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurance companies and the aging of the population are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from Kalorama Information, details these factors and provides 2011 market size and forecast to 2015 for...
DNA Microarray Market Trends (Installed Base, Applications, Purchase Plans and The Impact of Next-Gen Sequencing)
Published: November 1, 2011 | Price: $150.00 – $300.00
DNA Microarrays are utilized heavily by research labs for a number of tasks such as gene profiling, RNA detection and SNP analysis. But as Kalorama Information's DNA Market Trends report indicates, the market for these systems is about to experience change. The report authored by Kalorama Information biotech analyst Justin Saeks, is the result of surveys carried out with microarray labs to determine the current state of the microarray market and attempt to predict the future direction of the technologies....
China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets (Market Size Estimates, Regional Healthcare Market Breakouts, Demographics and Regulation)
Published: October 15, 2011 | Price: $150.00 – $300.00
China's rapid economic development and the numerous steps of reform undertaken by the Chinese central government since 1997 have had clear and observable effects upon China's total healthcare services market and its product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, which includes increased funding to improve services. What are the workings of China's healthcare system? How much progress has been made towards the promised vision of...
Cell Culture: The World Market for Media, Sera and Reagents, 3rd Edition
Published: October 15, 2011 | Price: $150.00 – $300.00
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects. Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological...
Point of Care Diagnostics for Emerging Infectious Disease Threats (Dengue Fever, HIV, HPV, STDs, Chagas, TB, and Other IDs): Market Analysis and Technical Considerations
Published: October 1, 2011 | Price: $150.00 – $300.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...
Remote and Wireless Patient Monitoring Markets
Published: August 1, 2011 | Price: $150.00 – $300.00
Advanced patient monitoring systems that provide wireless or remote patient monitoring to share data outside the immediate patient care area continue to see sales growth. Features on these devices can range from basic remote tracking ability to “face-to-face” interaction between clinicians and patients, or even data sorting of the vast amount of data collected in order to put it into the context of a patient’s condition. Many systems now transfer data to an electronic medical record (EMR), and some come...
Image-Guided Surgery (X-Ray, CT, PET, MRI and Ultrasound in Brain Surgery, Spinal Surgery and Other Applications)
Published: August 1, 2011 | Price: $150.00 – $300.00
Imaging technology used to diagnose illness and injury is increasingly being used to assist surgeons complete procedures. Image-guided surgery involves the use of a real-time correlation of the operative field to preoperative imaging data that reflect the precise location of a surgical instrument to the surrounding anatomical structures. Preoperative scans from different imaging modalities provide additional diagnostic information. These scans can help a surgeon assess the adequacy of a repair. As the number of minimally invasive surgical procedures has increased,...
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics
Published: July 1, 2011 | Price: $150.00 – $300.00
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the analysis in this report. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry and the needle-free drug delivery market will continue to grow rapidly. This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives...
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
Published: July 1, 2011 | Price: $150.00 – $300.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The industry has responded with a variety of testing and treatment products. This report, Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,...